» Articles » PMID: 39596959

Multisystem Inflammatory Syndrome in Children (MIS-C) in a Lithuanian Paediatric Tertiary Care Center

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Nov 27
PMID 39596959
Authors
Affiliations
Soon will be listed here.
Abstract

: Due to its link with the SARS-CoV-2, Multisystem Inflammatory Syndrome in Children (MIS-C) gained global attention as a serious condition that requires hospital care. Our study aimed to present the clinical and laboratory characteristics of MIS-C patients by age group and intensive care unit (ICU) admission status and assess early echocardiographic changes. : A single-center partly retrospective, partly prospective observational cohort study was performed from December 2020 to June 2024. The study included 42 patients aged between 1 month and 18 years who were diagnosed with MIS-C and gave informed consent. : The median age was 6.5 years (IQR 2.0-9.3). The predominant symptoms were cardiovascular (88.1%), mucocutaneous (85.7%) and gastrointestinal (76.2%). Five children (11.9%) developed shock. About two-thirds of patients (66.7%) were admitted to the ICU. Adolescents (≥12 years) were less likely to exhibit mucocutaneous or cardiovascular symptoms and thus less frequently having Kawasaki-like disease symptoms compared with other age groups (<5 years or 5-11 years). Lymphopenia was more common among patients aged 5 years and older. Adolescents had higher procalcitonin (PCT) and a lower estimated glomerular filtration rate. Troponin I and B-type natriuretic peptide (BNP) levels were higher in children aged 5-11 years, while ferritin levels were lower among the youngest (<5 years). Patients treated at the ICU were more likely to have cardiovascular and respiratory symptoms, as well as a history of symptomatic COVID-19, higher C-reactive protein (CRP), PCT, BNP and lower albumin levels. Echocardiographic abnormalities were found in 71.4% of cases. During hospitalization, left ventricular ejection fraction values increased significantly ( < 0.001) over 12 (IQR 9.0-14.0) days. : Symptoms and laboratory markers of MIS-C vary according to age. Higher CRP, PCT, BNP and hypoalbuminemia are predictors of MIS-C severity. Cardiovascular involvement is common and might be severe, but rapid resolution is encouraging.

References
1.
Ooms C, Mossong J, Vergison A, Biver A, Wagner K, Niel O . Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg. Front Pediatr. 2023; 11:1141074. PMC: 10113488. DOI: 10.3389/fped.2023.1141074. View

2.
Ludwikowska K, Moksud N, Tracewski P, Sokolski M, Szenborn L . Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland. Biomedicines. 2023; 11(5). PMC: 10215748. DOI: 10.3390/biomedicines11051251. View

3.
Friedman K, Harrild D, Newburger J . Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action. J Am Coll Cardiol. 2020; 76(17):1962-1964. PMC: 7572056. DOI: 10.1016/j.jacc.2020.09.002. View

4.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608. PMC: 7204765. DOI: 10.1016/S0140-6736(20)31094-1. View

5.
Pino R, Antonanzas J, Paredes-Carmona F, Perramon A, Riviere J, Coma M . Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain. Eur J Pediatr. 2023; 182(4):1897-1909. PMC: 9937862. DOI: 10.1007/s00431-023-04862-z. View